S. A. Maillard

Long-lasting stem cell–like memory CD8+ T cells with a naïve-like profile upon yellow fever vaccination

M. Delorenzi, D. Speiser, C. Soneson, 2015, Science Translational Medicine.

Ventilatory settings in the initial 72 h and their association with outcome in out-of-hospital cardiac arrest patients: a preplanned secondary analysis of the targeted hypothermia versus targeted normothermia after out-of-hospital cardiac arrest (TTM2) trial

John A Sanner, C. Callaway, R. Bellomo, 2022, Intensive Care Medicine.

Ventilatory settings in the initial 72 h and their association with outcome in out-of-hospital cardiac arrest patients: a preplanned secondary analysis of the targeted hypothermia versus targeted normothermia after out-of-hospital cardiac arrest (TTM2) trial.

John A Sanner, C. Callaway, R. Bellomo, 2022, Intensive care medicine.

Pembrolizumab-triggered Uveitis: An Additional Surrogate Marker for Responders in Melanoma Immunotherapy?

R. Dummer, D. Speiser, S. Goldinger, 2016, Journal of immunotherapy.

Oxygen targets and 6-month outcome after out of hospital cardiac arrest: a pre-planned sub-analysis of the targeted hypothermia versus targeted normothermia after Out-of-Hospital Cardiac Arrest (TTM2) trial

John A Sanner, C. Callaway, R. Bellomo, 2022, Critical Care.

Axonal marker neurofilament light predicts long-term outcomes and progressive neurodegeneration after traumatic brain injury

Maneesh C. Patel, Maria Yanez Lopez, D. Sharp, 2021, Science Translational Medicine.

Treatments for intracranial hypertension in acute brain-injured patients: grading, timing, and association with outcome. Data from the SYNAPSE-ICU study

Justin D. Roberts, G. Meyfroidt, H. Sapra, 2023, Intensive Care Medicine.

Vaccination of stage III/IV melanoma patients with long NY-ESO-1 peptide and CpG-B elicits robust CD8+ and CD4+ T-cell responses with multiple specificities including a novel DR7-restricted epitope

D. Speiser, P. Baumgaertner, P. Romero, 2016, Oncoimmunology.